Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NKTR-181 in chronic low back pain
NCT02362672Phase 3Completed
- Sponsor
- Nektar Therapeutics
- Start
- Mar 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of loxicodegol in chronic low back pain (CLBP), sponsored by Nektar Therapeutics. Started Mar 2015; status: completed.
02
Drugs
loxicodegol
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT02362672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02362672.